Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 25 of Bolt Biotherapeutics, Inc.'s SEC filings and found 1 warrant series, 2 convertibles and 2 completed offerings on file for BOLT. The latest dilution event on file is an offering on Oct 23, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ALLRAllarity Therapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
ABOSAcumen Pharmaceuticals, Inc.
AEONAEON Biopharma, Inc.
MRKRMarker Therapeutics, Inc.
JSPRJasper Therapeutics, Inc.
ATYRaTyr Pharma, Inc.
PLURPluri Inc. Common Stock
ESLAEstrella Immunopharma, Inc.
RADXRadiopharm Theranostics Limited American Depositary Shares
NCELNewcelX Ltd. Ordinary Shares
HEPAHepion Pharmaceuticals, Inc.
CTXRCitius Pharmaceuticals, Inc.
KYNBKyntra Bio, Inc.
QNTMQuantum BioPharma Ltd.